Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x11405251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance

PPAR Research
Drug DiscoveryPharmacology
2009English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Impaired Expression of the Peroxisome Proliferator–activated Receptor Alpha During Hepatitis C Virus Infection

Gastroenterology
HepatologyGastroenterology
2005English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors Α

Frontiers in Pharmacology
Pharmacology
2019English

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

Peroxisome Proliferator-Activated Receptors in Atherosclerosis and Inflammation—An Update

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2001English

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma

PPAR Research
Drug DiscoveryPharmacology
2020English

Peroxisome Proliferator-Activated Receptor

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy